HIA
PFE icon

Harbor Investment Advisory’s Pfizer PFE Stock Holding History

Harbor Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Hold
8,425
– – 0.01% 417
2026
Q1 		$237K Sell
8,425
-630
-7% -$16.8K 0.02% 369
2025
Q4 		$225K Sell
9,055
-73
-0.8% -$1.84K 0.02% 386
2025
Q3 		$233K Sell
9,128
-479
-5% -$11.8K 0.02% 370
2025
Q2 		$233K Sell
9,607
-4,073
-30% -$95K 0.02% 351
2025
Q1 		$347K Sell
13,680
-887
-6% -$23.2K 0.03% 294
2024
Q4 		$386K Sell
14,567
-24,706
-63% -$670K 0.04% 264
2024
Q3 		$1.14M Sell
39,273
-15,164
-28% -$442K 0.11% 145
2024
Q2 		$1.52M Sell
54,437
-7,013
-11% -$193K 0.16% 101
2024
Q1 		$1.71M Buy
61,450
+27,284
+80% +$757K 0.18% 96
2023
Q4 		$984K Sell
34,166
-2,430
-7% -$73.5K 0.11% 143
2023
Q3 		$1.21M Buy
36,596
+6,390
+21% +$226K 0.16% 112
2023
Q2 		$1.11M Buy
30,206
+2,908
+11% +$113K 0.15% 125
2023
Q1 		$1.11M Buy
27,298
+3,321
+14% +$143K 0.17% 121
2022
Q4 		$1.23M Buy
23,977
+825
+4% +$39.6K 0.19% 104
2022
Q3 		$1.01M Sell
23,152
-10
-0% -$486 0.17% 114
2022
Q2 		$1.21M Buy
23,162
+14
+0.1% +$713 0.19% 99
2022
Q1 		$1.2M Buy
23,148
+1,819
+9% +$94.4K 0.16% 115
2021
Q4 		$1.26M Buy
21,329
+477
+2% +$23.6K 0.16% 115
2021
Q3 		$897K Sell
20,852
-824
-4% -$36.5K 0.12% 145
2021
Q2 		$849K Buy
21,676
+615
+3% +$23.9K 0.12% 155
2021
Q1 		$763K Sell
21,061
-4,812
-19% -$171K 0.11% 151
2020
Q4 		$952K Buy
25,873
+1,866
+8% +$68.4K 0.15% 116
2020
Q3 		$836K Buy
24,007
+401
+2% +$14.1K 0.16% 115
2020
Q2 		$732K Buy
23,606
+2,546
+12% +$86.5K 0.16% 116
2020
Q1 		$652K Sell
21,060
-6,875
-25% -$234K 0.18% 108
2019
Q4 		$1.04M Buy
+27,935
New +$995K 0.24% 94

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Harbor Investment Advisory's PFE Position: Q2 2026 in Review

Harbor Investment Advisory held its Pfizer (PFE) position steady in Q2 2026 at 8,425 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #417.

Harbor Investment Advisory first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.71M in Q1 2024. 991 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Harbor Investment Advisory held 8,425 shares of Pfizer worth $203K as of Q2 2026.
  • Harbor Investment Advisory left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #417 holding.
  • Harbor Investment Advisory first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Pfizer position peaked at $1.71M in Q1 2024.
  • 991 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.